Literature DB >> 22535274

REPRINT: International, multicenter randomized preclinical trials in translational stroke research: it is time to act.

Ulrich Dirnagl, Marc Fisher.   

Abstract

Entities:  

Year:  2012        PMID： 22535274     DOI： 10.1161/STROKEAHA.112.653709

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  6 in total

1.  Animal models in today's translational medicine world.

Authors:  Abhishek Choudhary; Jamal A Ibdah
Journal:  Mo Med       Date:  2013 May-Jun

Review 2.  Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress.

Authors:  Kim A Radermacher; Kirstin Wingler; Friederike Langhauser; Sebastian Altenhöfer; Pamela Kleikers; J J Rob Hermans; Martin Hrabě de Angelis; Christoph Kleinschnitz; Harald H H W Schmidt
Journal:  Antioxid Redox Signal       Date:  2012-10-16       Impact factor: 8.401

Review 3.  Bringing rigour to translational medicine.

Authors:  David W Howells; Emily S Sena; Malcolm R Macleod
Journal:  Nat Rev Neurol       Date:  2013-11-19       Impact factor: 42.937

Review 4.  Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies.

Authors:  Surojit Paul; Eduardo Candelario-Jalil
Journal:  Exp Neurol       Date:  2020-11-02       Impact factor: 5.330

Review 5.  Neuroprotection for stroke: current status and future perspectives.

Authors:  Jens Minnerup; Brad A Sutherland; Alastair M Buchan; Christoph Kleinschnitz
Journal:  Int J Mol Sci       Date:  2012-09-18       Impact factor: 6.208

6.  Inflammatory findings on species extrapolations: humans are definitely no 70-kg mice.

Authors:  Marcel Leist; Thomas Hartung
Journal:  Arch Toxicol       Date:  2013-03-19       Impact factor: 5.153
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.